A Study to Test How Well Empagliflozin Works in Japanese People With Type 2 Diabetes Who Are Older Than 65 Years
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 129 participants.
Also called NCT04531462
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 129 participants
- Sponsor
- Registry
-
NCT04531462
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Japan
- Registry status
- Completed
Technical summary
Registry record NCT04531462. Randomized; quadruple masking; primary purpose treatment. Start 2020-10-05 (actual); primary completion 2022-08-19 (actual). Results posted on 2024-03-12.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Test How Well Empagliflozin Works in Japanese People With Type 2 Diabetes Who Are Older Than 65 Years
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Drug)
- Empagliflozin
- Intervention (Drug)
- Placebo
- Lead sponsor
- Boehringer Ingelheim
Record details
- Record id
cardio:ct-nct04531462- Content hash
98c6da17093428fa168eaad3c9ae4965ae342f7e18507e1db91c09837ac0a0f7